US Patent Issued to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL on Oct. 21 for "Aryl aminopyrimidines as dual MerTK and TYRO3 inhibitors and methods thereof" (American, Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,365, issued on Oct. 21, was assigned to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (Chapel Hill, N.C.).

"Aryl aminopyrimidines as dual MerTK and TYRO3 inhibitors and methods thereof" was invented by Xiaodong Wang (Chapel Hill, N.C.), Yubai Zhou (Cary, N.C.), Ransheng Ding (Binhai New District, China), Deyu Kong (Chapel Hill, N.C.) and Stephen Frye (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aminopyrimidine containing compounds that inhibit both Mer tyrosine kinase (MerTK) activity and Tyro3 kinase activity are disclosed herein. Additionally disclosed are methods of synthesis and use of the aminopyrimidine containing compou...